EXTRA VISUAL INDEPENDENCE
AT ALL DISTANCES
The highly functional optical design of TRIVA® enables extra visual independence thanks to continuous progressive vision. Your patients benefit from excellent visual results, starting with a comprehensively usable near range of 33 cm, through the various intermediate ranges to the distance range. The smart design ensures a high level of acceptance of multifocal side effects.
SMART FACTS
CONTINUOUS GLIDING VIEW
The wide focal plateau of TRIVA® allows most activities of daily living to be performed independently, from reading a book to working on a PC or laptop to excellent distance vision. 92-100% of patients do not need a visual aid for distance, near and intermediate vision.1
BALANCED LIGHT DISTRIBUTION
Regardless of the pupil diameter, all areas of vision are always addressed. The weighting of the light distribution is adapted to the respective visual requirements. Under mesopic conditions and with a wide-open pupil, distance vision is emphasized more strongly, while around 40 % of the light energy is still available for the near and intermediate range.
HIGH ACCEPTANCE OF CONCOMITANT SYMPTOMS
By reducing the diffractive rings to a minimum, the occurrence of photopic phenomena is reduced. A low refractive index ensures fewer scattering effects. Cataract patients were little or not at all affected by multifocal side effects2 – for EXTRA-satisfied patients!
ADDITIONAL CORRECTION OF CORNEAL ASTIGMATISM
Of course, we also offer the TRIVA® as a toric version. TRIVA® T complements the range for patients with astigmatism. From 1.0 dpt astigmatism, we recommend choosing the toric TRIVA® T.
EXPERT OPINIONS ON THE TRIVA®
“The TRIVA® IOL exceeds my expectations. Patient satisfaction is remarkably high.”
Priv.-Doz. Dr. med. Jens Schrecker, Glauchau.
“In our experience, hydrophilic diffractive trifocal IOLS produce
fewer halos and glare.”
MUDr. Pavel Stodůlka, Ph.D., FEBOS-CR.
“The TRIVA® is my lens of choice for refractive Clear Lens Exchange patients. Here in particular, continuous vision, i.e. seamless progressive vision without major compromises at a distance, is an important prerequisite for Happy Patients. The high acceptance of the TRIVA® represents a new class of its own in my experience. For example, the TRIVA® significantly larger pupil displacement values and compensates for them. This is another reason why the TRIVA® is characterized by a pleasantly low chair time in my everyday practice.”
Prof. h.c. mult. Dr. med. Amir-Mobarez Parasta, DOC 2025.
TECHNICAL DATA
- Full Vision Range IOL for full range of vision
- Aspherical aberration-free
- 360° lens epithelial cell barrier
- Optics diameter 6.0 mm, total diameter 12.5 mm
- UV-absorbing hydrophilic acrylic (water content 26 % at 35° C)
- Blue light filter optionally available
- Toric version complements the range for patients with astigmatism
- Near addition +3.5 dpt, intermediate addition +1.75 dpt (at IOL level)
- Abbe number: 56
- Refractive index: 1.46
Triva®
WITHOUT BLUE LIGHT FILTER
WITH BLUE LIGHT FILTER
Triva® T
XL delivery area
PRELOADED IN THE SAFELOADER® | IN THE COMPACT LINE | ||
|---|---|---|---|
TRIVA®-aA /
TRIVA®-aAY | Near addition +3.5 dpt
Intermediate addition +1.75 dpt | 10.0 to 30.0 in 0.5 dpt steps | 10.0 to 30.0 in 0.5 dpt steps |
TRIVA® T-aAY | Near addition +3.5 dpt
Intermediate addition +1.75 dpt
| SE: 10.0 to 30.0 in 0.5 dpt increments Zyl: 1.0 to 6.0 in 0.5 dpt increments | The trifocal-toric version TRIVA® T also complements the range for patients with astigmatism. |
APPLICATION
Whether you opt for the space-saving Compact Line or the Safeloader preloaded implantation system, we recommend the Medicel AccuJectTM in the exclusive yellow HumanOptics version for both systems.
APPLICATION TEAM
Use our individual calculation service to find the right implant for your patient’s requirements together with us. We offer doctors the opportunity to contact us directly with the calculation values. We calculate the lens based on your specific measurement data!
Do you have medical or technical questions?
Our switchboard (+49 (0) 9131 50 66 5-0) gives you quick access to our specialist departments.
95 % OF OUR CUSTOMERS TRUST THEEXPERTISE OF OUR APPLICATION TEAM.3
REPORTS FROM CLINICAL APPLICATION
The excellent efficacy and safety of TRIVA® and TRIVA® T have been confirmed in clinical use.4,5
No matter how high the IOL quality, it is only as good as its practical usability. That is why experience reports are usually much more meaningful than theoretical technical data. See for yourself.
TRIVA®
First results after implantation of a new hydrophilic, trifocal intraocular lens
Schrecker J, Langenbucher A
First results after implantation of a new hydrophilic, trifocal intraocular lens
Article in Ophthalmologische Nachrichten, congress edition of the DOG 2023
First clinical results of the new TRIVA IOL for resilient presbyopia correction
Schrecker J
First clinical results of the new TRIVA IOL for resilient presbyopia correction
Presentation DGII 2021 March
New Trifocal IOL - TRIVA
Stodulka P
New Trifocal IOL – TRIVA
Presentation Zlin Ophthalmic Festival 2022
Our First Clinical Experience With New Trifocal Intraocular Lens
Schrecker J, Langenbucher A
First results after implantation of a new hydrophilic, trifocal intraocular lens
Presentation DOG 2023
Clinical results of a new trifocal intraocular lens
Schrecker J, Langenbucher A
Clinical results of a new trifocal intraocular lens
Presentation DOC 2024
TRIVA® T
Clinical Performance of an Omnidirectional Aberration-Free Trifocal Toric Intraocular Lens
Pastor-Pascual F, Orts-Vila P, Tañá-Sanz P,Tañá-Sanz S & Tañá-Rivero
Clinical Ophthalmology 2024:18 2009-2020
Clinical Performance of an Omnidirectional Aberration-Free Trifocal Toric Intraocular Lens
Do you have any questions or would you like to order our products?
Please contact our sales team for an individual consultation, specific information on our products or training measures and surgery shadowing.
Our employees are happy to be there for you EXTRA.
- Stodulka P. First clinical experience with the Triva trifocal IOL. Presented at the ZOF 2022 Congress, Prague, Czech Republic.
- Stodulka P, Slovak M. Our first clinical experience with a new trifocal intraocular lens. Presented at the ESCRS 2023 Congress, Vienna, Austria.
- HumanOptics Data on File, 2021.
- Gyöngyössy B, Jirak P, Schönherr U. Rotational stability and patient satisfaction after implantation of a new toric IOL. Eur J Ophthalmol. 2016 Jun 10;26(4):321-7.